Preclinical pharmacology services by a leading CRO
The preclinical pharmacology studies are an important step in the Drug Discovery process. They generate rich and quality data on the drug candidate behavior, enabling the translation of findings from the laboratory to the clinic.
The priority is to achieve the efficacy and the safety of a new molecular entity. For that, several criteria must be established on the candidate during the preclinical pharmacology studies such as :
CRO services can help you in your preclinical pharmacology project to accelerate your research programs.
Oncodesign Services, a CRO dedicated to preclinical development and translational pharmacology
The Oncodesign Services preclinical pharmacology department gathers experts in Drug Discovery to support your research programs. Our laboratories are BSL1, BSL2 and BSL3 and AAALAC accredited for our animal care and use program, dedicated to provide high quality data for preclinical pharmacology studies.
Based in Dijon, Paris and Montreal, our scientific teams work with pharmaceutical companies and biotech, belong SOLO or INTEGRATED programs, from hit identification to IND-finding.
Oncodesign Services offers various Preclinical pharmacology services such as:
-
Efficacy models on various therapeutic areas
- A large bank of characterized tumor models (orthotopic, metastatic, humanized…)
- Inflammatory pathologies
- Infectious diseases
- Pharmacology studies
-
Toxicology studies (with partners)
- In vitro toxicology studies
- In vivo toxicology studies
This integrated approach can completely be tailored to your specific needs. Based on our extensive experience, Oncodesign Services’ team offers support along your projects with accelerated cycles times and the latest innovative technologies.
Do you want to know more about our capabilities in pharmacology ? Contact us!
